Mucopolysaccharidosis, Type Ii, also known as hunter syndrome, is related to mucopolysaccharidosis with skin involvement and mucopolysaccharidosis-plus syndrome, and has symptoms including diarrhea, hoarseness and seizures. An important gene associated with Mucopolysaccharidosis, Type Ii is IDS (Iduronate 2-Sulfatase), and among its related pathways/superpathways are Metabolism and Glycosaminoglycan metabolism. The drugs Rituximab and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include spinal cord and skin, and related phenotypes are macrocephaly and muscle weakness